Farallon Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.74M Hold
3,319
0.01% 97
2025
Q4
$1.93M Hold
3,319
0.01% 79
2025
Q3
$1.52M Hold
3,319
0.01% 84
2025
Q2
$1M Hold
3,319
﹤0.01% 91
2025
Q1
$1.1M Hold
3,319
0.01% 93
2024
Q4
$1.02M Hold
3,319
0.01% 98
2024
Q3
$704K Hold
3,319
﹤0.01% 108
2024
Q2
$930K Hold
3,319
0.01% 109
2024
Q1
$886K Hold
3,319
0.01% 122
2023
Q4
$768K Hold
3,319
﹤0.01% 109
2023
Q3
$485K Hold
3,319
﹤0.01% 118
2023
Q2
$767K Sell
3,319
-160,500
-98% -$43.5M ﹤0.01% 126
2023
Q1
$39.7M Buy
163,819
+10,819
+7% +$2.95M 0.24% 65
2022
Q4
$44.4M Buy
+153,000
New +$15M 0.29% 65

Other funds holding MDGL